Winn, Aaron N <br/><br/>
Factors Associated With Tyrosine Kinase Inhibitor Initiation and Adherence Among Medicare Beneficiaries With Chronic Myeloid Leukemia.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  12 2016 
 - 4323-4328 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2016.67.4184  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Cohort Studies<br/>Dose-Response Relationship, Drug<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--diagnosis<br/>Male<br/>Medicare--economics<br/>Patient Compliance--statistics & numerical data<br/>Prognosis<br/>Proportional Hazards Models<br/>Protein Kinase Inhibitors--therapeutic use<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Retrospective Studies<br/>Risk Assessment<br/>SEER Program<br/>Survival Rate<br/>Treatment Outcome<br/>United States<br/>Assessment of Medication Adherence